Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand.

Slides:

Advertisements

Similar presentations

DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.

Advertisements

Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.

Anne Sholander, MT(ASCP), International QA/QC Coordinator, SMILE

Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.

The Roadmap to Successful Xpert Implementation - 37 steps -

Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.

MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014.

Improving diagnosis TB laboratory strengthening.

Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.

Standards for Laboratory Diagnosis of Tuberculosis Professor Brian I. Duerden Inspector of Microbiology and Infection Control, Department of Health.

Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.

International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.

GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)

Laboratories And EQA for effective Tuberculosis Control Programe

KEY CHANGES IN THE NEW NTBLCP GUIDELINES

Country Progress Report Philippines

Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.

Country Progress Report VIET NAM

COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.

1 Module PLANNING AND ORGANIZING EXTERNAL QUALITY ASSESSMENT.

China TB Control Progress Report The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region.

Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.

COMPREHENSIVE APPROACH TO TB DIAGNOSIS

Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.

Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.

Innovation in TB control: what’s in it for the field? Peter C.F.M. Gondrie, MD, MPH Executive Director

Module 4: From Suspect to Confirmed Case. Learning Objectives Explain why sputum microscopy is important Describe the process for confirming a TB suspect.

Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.

ICAP Lesotho Transition Strategy for Sustainability M&E Technical Meeting.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

Experience establishing TB Laboratory capacity in Lesotho Dr Vollepore FIND.

TB DIAGNOSTICS R&D: Not Just Technology Peter Mehlape, General Manager GBC Southern Africa Conference 11th October 2010, Johannesburg BD Experience with.

1 Module OVERVIEW OF EXTERNAL QUALITY ASSESSMENT.

Monitoring Drug Resistant Tuberculosis Treatment in Brazil through an Innovative Web-based Information System Dr. Luis Gustavo Bastos Management Sciences.

Programmatic Management of Multidrug Resistant TB (PMDT) 5 th Joint International Monitoring Mission of NTP, Thailand 23 August, 2013.

Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,

Point of Care testing (POCT) For Sexually Transmitted Infections (STI) Barbara Bewley Operations Manager Pathology Clinical Services.

CLINICAL DIAGNOSTIC TB LABORATORY Alexander Sloutsky, Director University of Massachusetts Supranational Reference TB Laboratory Boston, MA.

TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.

Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.

Large Hospitals DEWG – Group Work Report. Participants Indonesia Philippines South Africa Viet Nam Korea China Partners: KNCV, WHO, Gates.

June 30, 2010 TB Program Thailand MOPH – U.S. CDC Collaboration TB Project Implementation: Impact on NTP?

1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.

PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.

Tuberculosis control in Suriname Situational analysis.

Name of LGU Accomplishment Report NTP Year-End Evaluation and Planning Workshop November 23-27, 2009.

Role of Laboratory Services in TB Control Dr Mohammad Rahbar Professor of Microbiology Department Microbiology Reference health Laboratory,Tehran iran.

Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.

Mobilizing Single Practice Providers for DOTS Network Service Delivery Marilou P. Costello, PhD Elmer S. Soriano, MD Philippine Tuberculosis Initiative.

Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.

REMoxTB – a microbiological challenge Dr Anna Bateson Dr. Tim McHugh, Robert Hunt, Emma Cunningham (Emily Bongard, Holly Ciesielczuk)

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.

TB – LABORATORY INVESTIGATIONS by Dr. Zubaidah Abdul Wahab Datin Dr. Ganeswrie Raj 1.

Monitoring and Evaluation Frameworks

NATIONAL outreach Network

World Tuberculosis Day 2014

Summary of changes in the RNTCP technical guidelines in

P.-Y. Lévy Clinical Microbiology and Infection

Introducing new drugs and shorter regimen

World Tuberculosis Day 2014

Update on SBCC Activities of Challenge TB Bangladesh

5th edition NTP MANUAL OF PROCEDURES Introduction and Highlights

Deciphering TB Lab Reports

5th DEWG meeting Conclusions

The STOP TB Strategy – 2009 VISION: A TB-free world

Background & rational DEWG meeting 2009

Utilization of Audio visual medium for conveying sputum collection instructions for tuberculosis diagnosis Presenter: Fred ORINA.

Monitoring and Evaluation: A Review of Terms

Multi-disease diagnostic integration

Presentation transcript:

Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand

 Functional quality assured nationwide smear microscopy network (1081)  Current 5 year plan for network of 66 culture labs, 32 FLDST labs is under progress, to be completed 2015  Second Line DST available (MGIT) at NTRL Bangkok (SRL) and Siriraj/Ramathibodi University Hospital (will need to be proficiency tested by NTRL /SRL  Molecular diagnostics LPA (Hain – 12) (YD - 4) RT PCR (GeneXpert -14) (Seegene - 8) 5th JMM Thailand

 National policy for sputum collection for diagnosis and follow-up during treatment not uniformly followed  Quality of sputum, staining variable (volume, salivary specimen)  Low smear positivity rate (use of kinyoun cold staining, low sensitivity of conventional light microscopy)  Culture and DST facilities and molecular tools under- used for diagnosis and follow up of TB and DR TB  Laboratory information systems not synchronized with clinical information systems  Many laboratories outside DDC system perform TB diagnostics; not monitored or effectively included in policy dissemination  Laboratories not accredited for TB diagnostic services (culture & DST) 5th JMM Thailand

 Address sputum specimen quality, safety ◦ Strictly implement sputum collection policy (especially the 2 nd early morning specimen) ◦ Improve sputum quality by training and education of HCW and patients  To improve smear microscopy sensitivity ◦ Replace Kinyoun cold staining with Ziehl-Neelsen staining ◦ Replace conventional microscopy with LED FM in appropriate settings  Expand access and rational use of newer more sensitive molecular tools to improve case detection of all forms of TB including DR TB  Optimally utilize the culture and DST facilities for management of TB and DR TB 5th JMM Thailand

 Link the LMIS to electronic case record system and build capacity for analysis of laboratory indicators to improve performance and throughput  Develop strategies to engage all laboratories with policy and quality standards, beyond DDC network  Enhance quality supervision for EQA (smear) through NTRL/RRL  Ensure that all laboratories providing TB diagnostic services are accredited 5th JMM Thailand

Thank You 5th JMM Thailand